Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

altRX vs NuBloom

altRX and NuBloom both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
altRX logo

altRX

7.6
★★★★☆3.8/5

Best for: semaglutide from $1149/month

Visit altRX →
VS
NuBloom logo

NuBloom

7.0
★★★★☆3.5/5

Best for: starting below a standard dose, with microdose tiers

Visit NuBloom →

If you are choosing between altRX and NuBloom, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. altRX leads our six-part score, 7.6 to 7.0. One of the two has an FDA warning letter on record, covered below.

altRX vs NuBloom price

altRX and NuBloom start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $149 a month; tirzepatide costs the same at both, $249 a month.

Medications and formats

Both sell semaglutide and tirzepatide.

On format, altRX prices compounded injections and brand-name pens, while NuBloom prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, altRX is the only one of the two with a brand-name price.

Where each one treats patients

altRX lists 50 states, and NuBloom lists 49 states.

They overlap in 49 states. altRX alone covers Mississippi.

Pricing

altRX

Compounded GLP-1 (semaglutide) starting tierCompounded
$149/mo
semaglutide
Compounded GLP-1/GIP (tirzepatide) starting tierCompounded
$249/mo
tirzepatide
Brand-name Ozempic®Brand-name
$1149/mo
semaglutide
Brand-name Mounjaro®Brand-name
$1249/mo
tirzepatide
Brand-name Zepbound®Brand-name
$1249/mo
tirzepatide
Brand-name Wegovy®Brand-name
$1579/mo
semaglutide

NuBloom

Compounded semaglutide (0.25–2.4 mg)Compounded
$149/mo
semaglutide

Homepage/product page: '$149/mo ... Once-weekly GLP-1 Injections, month to month subscription.' Single monthly price with doses 0.25/0.5/1/1.7/2/2.4 mg listed; BMI 27+.

Compounded tirzepatide (2.5–15 mg)Compounded
$279/mo
tirzepatide

Product page: '$279/mo. Once-weekly GLP-1/GIP Injections, month-to-month subscription.' Doses 2.5/5/7.5/10/12.5/15 mg listed; BMI 27+.

Compounded microdose tirzepatideCompounded
$249/mo
tirzepatide

Microdose Tirzepatide product page: '$249/mo ... Month to month subscription.'

What each price covers

Both prices cover the medication itself.

altRX's price also covers the clinician visit and shipping, which NuBloom does not claim.

altRX is silent on lab work and coaching.

NuBloom is silent on the clinician visit, shipping, lab work and coaching.

altRX

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

NuBloom

Covered by the monthly price

Medication

In the price

Clinician visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, altRX scores 7.6 and NuBloom 7.0 out of 10.

altRX is stronger on user experience (8.0 vs 3.0) and support (7.0 vs 5.0).

NuBloom is stronger on value (6.6 vs 5.0).

Effectiveness, trust & safety and accessibility are within half a point.

How we score

altRX

7.6/10

Overall

NuBloom

7.0/10

Value25%

5.0A
vs
B
6.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
6.0

Accessibility10%

10.0A
vs
B
9.8

Support10%

7.0A
vs
B
5.0

FDA warning letters

The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.

NuBloom has no FDA warning letter on record with us.

Features & Coverage

FeaturealtRXNuBloom
Starting Price$149/mo$149/mo
Features8 features8 features
States Available✓5049
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About altRX

Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.

Read our full altRX review →

About NuBloom

Dose ladders are shown in the open, and subscriptions run month to month: $149/month at the start for compounded semaglutide, $279/month for compounded tirzepatide. Coaching arrives with a guided 90-day program at $599/month. Dr. Marianne Pinkston Mueller, a physician in family and integrative medicine, founded this women's metabolic-health practice, which handles longevity, gut-health and hormone care as well. An affiliated telehealth network carrying LegitScript certification delivers it across 49 states. FDA approval does not extend to compounded medications.

Read our full NuBloom review →

Pros & Cons

altRX

What we like

  • Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • Names 4 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Semaglutide costs $1149 a month, 15% above the $997 median for brand-name semaglutide across the sellers we compare
  • The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

NuBloom

What we like

  • Semaglutide costs $149 a month, 19% below the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $249 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • The monthly price includes the medication
  • Serves 49 states
  • We found no FDA warning letters issued to NuBloom

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: altRX

altRX wins this one, 7.6 to 7.0, above all for semaglutide from $1149/month. NuBloom fits better if starting below a standard dose, with microdose tiers is your priority.

Choose altRX if…

You want semaglutide from $1149/month and an opening price near $149 a month.

Choose NuBloom if…

You want starting below a standard dose, with microdose tiers and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Strut Health

Semaglutide at $99/month, 48% below the typical price

8.4

Enhance MD

Knowing which pharmacy fills the vial: it names Tru Meds Rx

6.1

DudeMeds

Compounded semaglutide at $175/month

altRX vs NuBloom: FAQ

Neither on the entry price: altRX and NuBloom both start at about $149 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
altRX: 50 states against 49, with 49 in common.
Both include the medication itself. Only altRX includes the clinician visit and shipping.
altRX has an open FDA warning letter from June 8, 2026. NuBloom has none.
No. Neither altRX nor NuBloom pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.